Physician profile
Stephen Meng
NPI 1083974257
$16,937.66
in general payments reported to CMS, 2019-2025
32 companies · $4,377 in 2025
The $4,377 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,600 · 2020: $411 · 2021: $690 · 2022: $549 · 2023: $755 · 2024: $8,557 · 2025: $4,377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,544 · Food and Beverage: $4,091 · Education: $52.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,544.15 |
| Food and Beverage | $4,091.27 |
| Education | $52.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $11,005.41 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,159.11 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $725.33 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $568.54 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $522.54 | 2019-2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $496.44 | 2019-2025 | Evkeeza |
| Astrazeneca Pharmaceuticals LP | $429.51 | 2019-2025 | Brilinta, Farxiga |
| Heartflow, INC. | $252.40 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $237.84 | 2019-2022 | |
| Esperion Therapeutics, INC. | $212.04 | 2021-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $132.21 | 2024-2025 | Lifevest |
| Kaneka Medical America LLC | $124.12 | 2019 | |
| W. L. Gore & Associates, INC. | $119.25 | 2024 | Gore Tag Conformable Thoracic Endoprosthesis |
| Abiomed | $106.91 | 2023 | Impella |
| Kestra Medical Technology Services, INC. | $99.29 | 2025 | Assure Wcd |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Okami Medical, INC. | $93.51 | 2024 | Lobo |
| Sanofi-Aventis U.S. LLC | $93.02 | 2019 | |
| Medtronic, INC. | $71.91 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $61.94 | 2024 | Arcalyst |
| Boston Scientific Corporation | $58.78 | 2019-2024 | Watchman Access System |
| Genzyme Corporation | $55.60 | 2022-2025 | |
| Ionis Pharmaceuticals, INC. | $53.55 | 2025 | Tryngolza |
| Bayer Healthcare Pharmaceuticals INC. | $44.57 | 2025 | |
| Chiesi USA, INC. | $33.63 | 2025 | Kengreal, Cleviprex, Juxtapid |
| Amarin Pharma, INC. | $32.51 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $31.97 | 2021 | |
| Preventice Services, LLC | $23.22 | 2019 | |
| Alnylam Pharmaceuticals INC. | $22.86 | 2025 | |
| Terumo Medical Corporation | $20.83 | 2024 | Angio-Seal |
| Actelion Pharmaceuticals US, INC. | $17.24 | 2025 | Uptravi, Opsumit |
| Lantheus Medical Imaging, INC. | $16.41 | 2021 | |
| Bridgebio Pharma, INC. | $15.17 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Meng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.